Expression of the LIS-1 gene product in brain anomalies with a migration disorder

Pediatr Neurol. 1997 Jan;16(1):42-4. doi: 10.1016/s0887-8994(96)00260-3.

Abstract

Miller-Dieker syndrome (MDS) is a prototype of brain malformations characterized by abnormal neuronal migration. To clarify the pathomechanisms underlying these anomalies, we performed immunohistochemical studies using specific antibodies against the protein product of LIS-1, the candidate gene responsible for the MDS phenotype. The LIS-1 protein was present abundantly and ubiquitously in normally developing brains. Loss of LIS-1 immunoreactivity was observed in brains with MDS, but not in brains with other malformations, such as isolated lissencephaly, holoprosencephaly, Fukuyama-type congenital muscular dystrophy, and Zellweger syndrome. These results suggest that the pathomechanism underlying abnormal neuronal migration in MDS may be specific to this particular type of malformation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • Adolescent
  • Adult
  • Brain / abnormalities*
  • Brain / pathology
  • Brain Diseases / genetics*
  • Brain Diseases / pathology
  • Cell Movement / genetics*
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Female
  • Gene Expression / physiology
  • Humans
  • Immunoenzyme Techniques
  • Infant
  • Infant, Newborn
  • Intellectual Disability / genetics*
  • Intellectual Disability / pathology
  • Male
  • Microtubule-Associated Proteins*
  • Neurons / pathology
  • Phenotype
  • Pregnancy
  • Proteins / genetics*
  • Syndrome

Substances

  • Microtubule-Associated Proteins
  • Proteins
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • PAFAH1B1 protein, human